Startseite Evaluation of a panel of circulating DNA, RNA and protein potential markers for pathologies of pregnancy
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Evaluation of a panel of circulating DNA, RNA and protein potential markers for pathologies of pregnancy

  • Silvia Galbiati , Vincenza Causarano , Pamela Pinzani , Salvianti Francesca , Claudio Orlando , Maddalena Smid , Federica Pasi , Maria T. Castiglioni , Paolo Cavoretto , Patrizia Rovere-Querini , Silvia Pedroni , Stefano Calza , Maurizio Ferrari und Laura Cremonesi
Veröffentlicht/Copyright: 8. April 2010
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: Among markers of pregnancy complications, corticotropin-releasing hormone (CRH) mRNA, long pentraxin 3 (PTX3) protein and fetal and total DNA had been reported to be increased in the plasma of women with overt preeclampsia (PE). We developed an optimized protocol to evaluate whether concentrations of CRH mRNA, PTX3 mRNA and protein, fetal and/or total DNA are increased in fetal growth restriction (FGR), and whether they predict complications of pregnancy.

Methods: The protocol included a preamplification step to enrich rare mRNA species. CRH and PTX3 mRNA, DNA and PTX3 protein were measured in the plasma of women with PE or FGR, in women at risk of developing these pathologies and in healthy women matched for gestational age.

Results:CRH mRNA, fetal and/or total DNA and PTX3 protein were significantly increased in women with overt PE when compared to controls. Pregnant women who later developed PE or FGR during pregnancy showed total DNA levels that were significantly increased before the onset of both pathologies, while RNA markers were increased only in women who later developed PE.

Conclusions: Our protocol for plasma RNA quantification may allow for the extension of a panel of predictive markers to be investigated in larger patient cohorts.

Clin Chem Lab Med 2010;48:791–4.


Corresponding author: Laura Cremonesi, Genomic Unit for the Diagnosis of Human Pathologies, Center for Genomics, Bioinformatics and Biostatistics, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, Italy Phone: +39 02 26434779, Fax: +39 02 26434351,

Received: 2009-11-9
Accepted: 2010-1-26
Published Online: 2010-04-8
Published in Print: 2010-06-01

©2010 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Editorials
  2. The “Obamanomics”: a revolution in laboratory diagnostics
  3. Skeletal muscle biomarkers: not new but still interesting diagnostic tools
  4. Necessity for high-quality reference materials in the harmonization of laboratory assays
  5. Reviews
  6. Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features
  7. Biochemical markers of muscular damage
  8. Minireview
  9. Interpretation of serum parathyroid hormone concentrations in dialysis patients: what do the KDIGO guidelines change for the clinical laboratory?
  10. Guidelines and Recommendations
  11. 2010 Consensus statement on the worldwide standardization of the hemoglobin A1c measurement
  12. Genetics and Molecular Diagnostics
  13. Development of a low-cost real-time reverse transcriptase-polymerase chain reaction technique for the detection and quantification of hepatitis C viral load
  14. Microsatellite polymorphisms in intron 2 of the toll-like receptor 2 gene and their association with susceptibility to pulmonary tuberculosis in Han Chinese
  15. Evaluation of a panel of circulating DNA, RNA and protein potential markers for pathologies of pregnancy
  16. General Clinical Chemistry and Laboratory Medicine
  17. Traceability of values for catalytic activity concentration of enzymes: a Certified Reference Material for aspartate transaminase
  18. Development and preparation of a new serum protein reference material: feasibility studies and processing
  19. A WHO Reference Reagent for the Serum Transferrin Receptor (sTfR): international collaborative study to evaluate a recombinant soluble transferrin receptor preparation
  20. Hyperhomocysteinemia is not associated with reduced bone quality in humans with hip osteoarthritis
  21. Diagnostic performance of anti-citrullinated peptide antibodies for the diagnosis of rheumatoid arthritis: the relevance of likelihood ratios
  22. New quantitative electrochemiluminescence method (ECLIA) for interleukin-6 (IL-6) measurement
  23. Evaluation of cell counting and leukocyte differentiation in cerebrospinal fluid controls using hematology analyzers by the German Society for Clinical Chemistry and Laboratory Medicine
  24. Reference Values and Biological Variations
  25. The relationship of coffee and green tea consumption with high-sensitivity C-reactive protein in Japanese men and women
  26. Cancer Diagnostics
  27. Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
  28. Identification of candidate molecular markers predicting chemotherapy resistance in non-small cell lung cancer
  29. Factors affecting soluble mesothelin related protein levels in an asbestos-exposed population
  30. Cardiovascular Diseases
  31. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome
  32. Performance characteristics of a microfluidic Lab-on-Chip electrophoresis system for high-density lipoprotein (HDL) subfraction separation and measurement
  33. Letters to the Editor
  34. Hemolysis correction factor in the measurement of serum neuron-specific enolase
  35. Serum paraoxonase-1 activity and genetic polymorphisms: common errors in measurement and interpretation of results
  36. Neuropharmacology of schizophrenia: is there a role for leptin?
  37. Relationship between serum concentrations of keratin-18 and apoptosis in chronic hepatitis C
Heruntergeladen am 7.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2010.160/pdf
Button zum nach oben scrollen